MyMetabolon Login
© 2020 Metabolon, Inc. All rights reserved.
Metabolon Metabolon
  • Metabolomics
    • About Metabolomics
    • Our Process
    • Technology & Knowledgebase
    • Setting the Standard: The 4Cs
    • Our Latest Insights
  • Solutions
    • Column 1
      • Products & Services
        • Global Metabolomics
        • Lipidomics
        • Targeted Assays
        • Study Design & Consulting
        • Sample Preparation & Handling
        • Study Success Sample Handling Kit
        • Reporting & Interpretation
        • Bioinformatics
        • MyMetabolon Client Portal
    • Column 2
      • By Research & Development Phase
        • Discovery & Target Selection
        • Lead Candidate Selection
        • Preclinical
        • Clinical Development
        • Manufacturing & Bioprocessing
    • Column 3
      • By Therapeutic Area
        • Cardiovascular Disease
        • COVID-19
        • Diabetes
        • Gastrointestinal
        • Liver Disease
        • Microbiome
        • Neuroscience
        • Oncology
        • Renal & Urological Disorders
        • Respiratory Disorders
    • Column 4
      • By Sector
        • Academic
        • Agriculture
        • Biotech / Pharmaceutical
        • Precision Medicine
        • Nutrition
        • Personal Care & Cosmetics
        • Population Health
        • Veterinary & Animal Health
  • Insights
    • Our Latest Insights
    • Blog
    • News & Events
  • Resources
    • Resource Library
    • Client Stories
    • COVID-19
  • Company
    • About Us
    • Working With Us (FAQ)
    • Leadership
    • Careers
    • Strategic Partnering
    • News & Events
    • Contact Us
MyMetabolon
Demo Our Data
Metabolon
Demo Our Data

Gastrointestinal

Understand gut disorders with function and focus to answer your question

Much about digestive diseases remains a mystery. Digestive disease includes a broad range of gastrointestinal-related health issues, ranging from chronic constipation to gastrointestinal infections to viral hepatitis. Irritable bowel syndrome (IBS) is estimated to impact between 25 and 45 million Americans and about 10-15 percent of the population worldwide. Although the exact cause of IBS is unknown, diet and microbiome are recurring influences.1 The unique ability for metabolomics to illuminate function, including those of microorganisms inhabiting the digestive tract, makes the technology a valuable tool for understanding IBS and other digestive conditions.

TALK WITH AN EXPERT
See More Solutions
Understand disease susceptibility

According to the National Institutes of Health (NIH), approximately 60 to 70 million people in the U.S. are affected by some type of digestive disease.2 With so many affected people and an estimated cost of $141.8 billion in the U.S., the unmet need to help diagnose and care for these patients is clear.2

Metabolomics can reveal actionable insights about state of health offering tremendous value to understanding disease susceptibility. Precision Metabolomics™ is an essential technology for investigating the interplay of genetics, diet and the microbiome in health maintenance and particularly in complex, multifactorial diseases of the digestive tract.

Decipher mechanisms in the gastrointestinal tract

Measuring the small molecules that serve as signals between microbial communities and the host has enabled a functional understanding of gut microbial activity. Metabolon deciphers thousands of discrete chemical signals and connects them in biological pathways that are not captured by other ‘omics, providing a definitive representation of the phenotype.

Identify biomarkers

Understanding the underlying biology of chronic diseases, like IBS, is important in identifying biomarkers that will enable disease prevention, detection, and optimal treatment efficacy. With our industry-leading library of over 5200 metabolites, Metabolon has the broadest coverage and capability to see potential biomarkers in your data. Combined with 20+ years of experience and our team of expert systems biologists, we are able to work more effectively together with you to design a biomarker-focused study that accelerates discovery, avoids roadblocks and provides the necessary actionable information for progressing your research.

1. International Foundation for Functional Gastrointestinal Disorders. Facts about IBS. Available at http://www.aboutibs.org/what-is-ibs/facts-about-ibs-2.html. Accessed 04-11-2017.

2. National Institute of Health. Digestive Diseases Statistics for the United States. Available at https://www.niddk.nih.gov/health-information/health-statistics/digestive-diseases. Accessed 06-02-2020.

Study Design

Data Interpretation

Our Platform

Learn More

Related Resources

See All Resources
Reflections of the Human Gut Microbiome in the Blood Metabolome

Reflections of the Human Gut Microbiome in the Blood Metabolome

Gastrointestinal, Global Metabolomics, Microbiome, Multi-Omics Integration, Targeted Assays, Webinars
Untargeted Metabolomics in Feces, a Functional Readout of Gut Microbial Activity

Untargeted Metabolomics in Feces, a Functional Readout of Gut Microbial Activity

Gastrointestinal, Global Metabolomics, Microbiome, Webinars
Metabolomics – A Key Technology for Microbiome Research

Metabolomics – A Key Technology for Microbiome Research

eBooks, Gastrointestinal, Global Metabolomics, Microbiome, Personal Care & Cosmetics, Targeted Assays
Load more

Enlighten your research,
accelerate your discovery.

Demo Our Data
or Talk With an Expert

Metabolomics

  • About Metabolomics
  • Our Process
  • Technology & Knowledgebase
  • Setting the Standard: The 4Cs
  • Insights & Discoveries

Solutions

  • Products & Services
  • By Research & Development Phase
  • By Therapeutic Area
  • By Sector

Insights

  • Our Latest Insights
  • Blog
  • News & Events

Resources

  • Resource Library
  • Client Stories
  • COVID-19

Company

  • About Us
  • Working With Us (FAQ)
  • Leadership
  • Careers
  • Strategic Partnering
  • News & Events
  • Contact Us
Metabolon - Logo - Enlightening Life

Metabolon provides actionable biological insights to answer the toughest questions in life sciences research and drug development.

© 2021 Metabolon, Inc. All rights reserved. Privacy & Terms

in
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.